Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | HK2 | P52789 | 4/20 | 0.52 |
| ▸ | HK1 | P19367 | 3/20 | 0.52 |
| ▸ | CD69 | Q07108 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N-Acetylglucosamine SCHEMBL22748755 | 1.00 | MAPK1 (0.63) | MAPK1LMNAKDM4ECYP2D6CYP2C19 | |
| N-Acetylglucosamine SCHEMBL22264045 | 1.00 | MAPK1 (0.63) | MAPK1LMNAKDM4ECYP2D6CYP2C19 | |
| N-Acetylglucosamine SCHEMBL22748805 | 1.00 | MAPK1 (0.63) | MAPK1LMNAKDM4ECYP2D6CYP2C19 | |
| N-Acetylglucosamine SCHEMBL22749039 | 1.00 | MAPK1 (0.63) | MAPK1LMNAKDM4ECYP2D6CYP2C19 | |
| N-Acetylglucosamine SCHEMBL24276732 | 1.00 | MAPK1 (0.63) | MAPK1LMNAKDM4ECYP2D6CYP2C19 | |
| N-Acetylglucosamine SCHEMBL20842453 | 1.00 | MAPK1 (0.63) | MAPK1LMNAKDM4ECYP2D6CYP2C19 | |
| N-Acetylglucosamine SCHEMBL24978032 | 1.00 | MAPK1 (0.63) | MAPK1LMNAKDM4ECYP2D6CYP2C19 | |
| N-Acetylglucosamine SCHEMBL25229254 | 1.00 | MAPK1 (0.63) | MAPK1LMNAKDM4ECYP2D6CYP2C19 | |
| N-Acetylglucosamine SCHEMBL24105621 | 1.00 | MAPK1 (0.63) | MAPK1LMNAKDM4ECYP2D6CYP2C19 | |
| N-Acetylglucosamine SCHEMBL21652639 | 1.00 | MAPK1 (0.63) | MAPK1LMNAKDM4ECYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11884961-B2 | DNA-glycan conjugates and methods of use | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2024-01-30 | — | — | US | claimed |
| US-20250361477-A1 | PRODUCTION OF AN OLIGOSACCHARIDE MIXTURE BY A CELL | INBIOSE NV (BE) | 2025-11-27 | — | — | US | disclosed |
| EP-4608849-A1 | SACCHARIDE IMPORTERS FOR LACTO-N-TRIOSE | Inbiose N.V. (BE) | 2025-09-03 | — | — | EP | disclosed |
| US-20250188503-A1 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | INBIOSE N.V. (BE) | 2025-06-12 | — | — | US | disclosed |
| US-20250188504-A1 | PRODUCTION OF A MIXTURE OF MAMMALIAN MILK OLIGOSACCHARIDES BY A CELL | INBIOSE N.V. (BE) | 2025-06-12 | — | — | US | disclosed |
| EP-4531836-A1 | WATER-SOLUBLE CANNABINOID PRODRUGS COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME | Trait Biosciences, Inc. (US) | 2025-04-09 | — | — | EP | disclosed |
| US-20250043253-A1 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | INBIOSE N.V. (BE) | 2025-02-06 | — | — | US | disclosed |
| EP-4493674-A1 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2025-01-22 | — | — | EP | disclosed |
| US-20240368651-A1 | CELLULAR PRODUCTION OF DI- AND/OR OLIGOSACCHARIDES | INBIOSE N.V. (BE) | 2024-11-07 | — | — | US | disclosed |
| EP-4448733-A1 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2024-10-23 | — | — | EP | disclosed |
| WO-2022034079-A2 | PROCESS FOR PURIFICATION OF AN OLIGOSACCHARIDE SOLUTION PRODUCED BY CELL CULTIVATION OR MICROBIAL FERMENTATION | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | disclosed |
| WO-2022034074-A1 | PRODUCTION OF OLIGOSACCHARIDE MIXTURES BY A CELL | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | disclosed |
| EP-3954778-A1 | PRODUCTION OF A MIXTURE OF NEUTRAL NON-FUCOSYLATED OLIGOSACCHARIDES BY A CELL | Inbiose N.V. (BE) | 2022-02-16 | — | — | EP | disclosed |
| EP-3954769-A1 | PRODUCTION OF OLIGOSACCHARIDE MIXTURES BY A CELL | Inbiose N.V. (BE) | 2022-02-16 | — | — | EP | disclosed |
| WO-2021160827-A2 | PRODUCTION OF GLYCOSYLATED PRODUCT IN HOST CELLS | INBIOSE N.V. (BE) | 2021-08-19 | — | — | WO | disclosed |
| WO-2021160828-A1 | KDO-FREE PRODUCTION HOSTS FOR OLIGOSACCHARIDE SYNTHESIS | INBIOSE N.V. (BE) | 2021-08-19 | — | — | WO | disclosed |
| WO-2021160829-A1 | VIABLE BACTERIAL HOST CELL | INBIOSE N.V. (BE) | 2021-08-19 | — | — | WO | disclosed |
| WO-2021160830-A1 | GLYCOMINIMIZED BACTERIAL HOST CELLS | INBIOSE N.V. (BE) | 2021-08-19 | — | — | WO | disclosed |
| WO-2021074182-A1 | PRODUCTION OF BIOPRODUCT IN A HOST CELL | INBIOSE N.V. (BE) | 2021-04-22 | — | — | WO | disclosed |
| WO-2020245320-A1 | OPTIMAL CHROMOSOMAL INSERTION LOCI | INBIOSE N.V. (BE) | 2020-12-10 | — | — | WO | disclosed |